2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
about
Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.
P2860
2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@en
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@nl
type
label
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@en
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@nl
prefLabel
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@en
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@nl
P2093
P1476
2,9-disubstituted-N6-(arylcarb ...... d molecular modelling studies.
@en
P2093
Anna Maria Bianucci
Barbara Costa
Edoardo Santini
Fatena Ahmad Nofal
Federica Pacchini
Giuliana Biagi
Iolanda Micco
Irene Giorgi
Laura Fabbrini
Michele Leonardi
P304
P356
10.1016/J.BMC.2005.04.063
P407
P50
P577
2005-08-01T00:00:00Z